RS-102221: A Novel High Affinity and Selective, 5-HT 2C Receptor Antagonist

Abramowski, 1995, Localization of the 5-hydroxytryptamine2C receptor protein in human and rat brain using specific antisera, Neuropharmacology, 34, 1635, 10.1016/0028-3908(95)00138-7

Akiyoshi, 1995, Rapid desensitization of serotonin 5-HT2C receptor-stimulated intracellular calcium mobilization in CHO cells transfected with cloned human 5-HT2C receptors, Journal of Neurochemistry, 64, 2473, 10.1046/j.1471-4159.1995.64062473.x

Audia, 1996, Potent, selective tetrahydro-β-carboline antagonists of the serotonin 2B (5HT2B) contractile receptor in the rat stomach fundus, Journal of Medical Chemistry, 39, 2773, 10.1021/jm960062t

Bagdy, 1992, Effect of 5-HT1C and 5-HT2 receptor stimulation on excessive grooming, penile erection and plasma oxytocin concentrations, European Journal of Pharmacology, 229, 9, 10.1016/0014-2999(92)90279-D

Battey J.F. et al. (1994) The RBI Handbook of Receptor Classification (J.W. Kebabian and J.L. Neumeyer Eds) Research Biochemicals International, Natick, MA.

Baxter, 1995, 5-HT2 receptor subtypes: a family re-united?, Trends in Pharmacological Science, 16, 105, 10.1016/S0165-6147(00)88991-9

Baxter, 1995, Novel discriminatory ligands for 5-HT2B receptors, Behavioural Brain Research, 73, 149, 10.1016/0166-4328(96)00087-3

Berendsen, 1990, Involvement of 5-HT1C-receptors in drug-induced penile erections in rats, Psychopharmacology, 101, 57, 10.1007/BF02253718

Bonhaus, 1995, The pharmacology and distribution of human 5-hydroxytryptamine2B (5-HT2B) receptor gene products: comparison with 5-HT2A and 5-HT2C receptors, British Journal of Pharmacology, 115, 622, 10.1111/j.1476-5381.1995.tb14977.x

Boyson, 1990, Net production of cerebrospinal fluid is decreased by SCH-23390, Annals of Neurology, 27, 631, 10.1002/ana.410270608

Brewerton, 1988, Induction of migraine like headaches by the serotonin agonist m-chlorophenylpiperazine, Clinical and Pharmacological Therapeutics, 43, 605, 10.1038/clpt.1988.83

Canton, 1990, Binding of typical and atypical antipsychotics to 5-HT1C and 5-HT2 sites: clozapine potently interacts with 5-HT1C sites, European Journal of Pharmacology, 191, 93, 10.1016/0014-2999(90)94100-C

Chen, 1994, Functional coupling of the 5-HT2C serotonin receptor to G proteins in Xenopus oocytes, Neuroscience Letters, 179, 100, 10.1016/0304-3940(94)90944-X

Cheng, 1973, Relationship between inhibition constant (Ki) and the concentration of inhibitor which causes 50 percent inhibition (ic50) of an enzymatic reaction, Biochemistry of Pharmacology, 92, 881

Conn, 1986, A unique serotonin receptor in choroid plexus is linked to phosphatidylinositol turnover, Proceedings of the National Academy of Science U.S.A., 83, 4086, 10.1073/pnas.83.11.4086

Curzon, 1991, Effects of tryptophan and of 5-hydroxytryptamine receptor subtype agonists on feeding, Advances in Experimental Medical Biology, 294, 377, 10.1007/978-1-4684-5952-4_35

Curzon, 1990, m-CPP: a tool for studying behavioural responses associated with 5-HT1C receptors, Trends in Pharmacological Science, 11, 181, 10.1016/0165-6147(90)90109-L

Duinkerke, 1993, Ritanserin, a selective 5-HT2/1C antagonist, and negative symptoms in schizophrenia. A placebo-controlled double-blind trial, British Journal of Psychiatry, 163, 451, 10.1192/bjp.163.4.451

Esterle, 1992, Serotonin agonists increase transferrin levels via activation of 5-HT1C receptors in choroid plexus epithelium, Journal of Neuroscience, 12, 4775, 10.1523/JNEUROSCI.12-12-04775.1992

Fiorella, 1995, 5-HT2C receptor-mediated phosphoinositide turnover and the stimulus effects of m-chlorophenyl piperazine, Psychopharmacology, 122, 237, 10.1007/BF02246545

Foguet, 1992, Structure of the mouse 5-HT1C, 5-HT2 and stomach fundus serotonin receptor genes, Neuroreport, 3, 345, 10.1097/00001756-199204000-00014

Forbes, 1993, N-(1-methyl-5-indolyl)-N′-(3-pyridyl)urea hydrochloride: the first selective 5-HT1C receptor antagonist, Journal of Medical Chemistry, 36, 1104, 10.1021/jm00060a019

Forbes, 1995, 5-Methyl-1-(3-pyridylcarbamoyl)-1,2,3,5-tetrahydropyrrolo[2,3-f]indole: a novel 5-HT2C/5-HT2B receptor antagonist with improved affinity, selectivity, and oral activity, Journal of Medical Chemistry, 38, 2524, 10.1021/jm00014a004

Fozard, 1989, 5-HT1C receptor activation: a key step in the initiation of migraine?, Trends in Pharmacological Science, 10, 307, 10.1016/0165-6147(89)90061-8

Galanopoulou, 1990, Behavioural changes on diet selection and serotonin (5-HT) turnover in rats under pizotifen treatment, Pharmacology and Biochemistry of Behaviour, 37, 461, 10.1016/0091-3057(90)90013-8

Grotewiel, 1994, m-chlorophenylpiperazine and m-trifluoromethylphenylpiperazine are partial agonists at cloned 5-HT2A receptors expressed in fibroblasts, Journal of Pharmacology and Experimental Therapeutics, 271, 1122

Hoffman, 1989, Distribution of serotonin 5-HT1C receptor mRNA in adult rat brain, FEBS Letters, 247, 453, 10.1016/0014-5793(89)81390-0

Hoyer, 1986, Serotonin receptors in the human brain., Brain Research, 376, 97, 10.1016/0006-8993(86)90903-0

Hoyer, 1994, International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin), Pharmacology Review, 46, 157

Kahn, 1991, m-Chlorophenylpiperazine as probe of serotonin function, Biological Psychiatry, 30, 1139, 10.1016/0006-3223(91)90184-N

Kaufman, 1995, Serotonin 5-HT2C receptor stimulates cyclic GMP formation in choroid plexus, Journal of Neurochemistry, 64, 199, 10.1046/j.1471-4159.1995.64010199.x

Kaufman, 1996, Cyclic GMP inhibits phosphoinositide turnover in choroid plexus: Evidence for interactions between second messengers concurrently triggered by 5-HT2C receptors, Neuroscience Letters, 206, 153, 10.1016/S0304-3940(96)12461-7

Kennett, 1994, Evidence that 5-HT2C receptor antagonists are anxiolytic in the rat Geller-Seifter model of anxiety, Psychopharmacology, 114, 90, 10.1007/BF02245448

Kennett, 1994, In vivo properties of SB 200646A, a 5-HT2C/2B receptor antagonist, British Journal of Pharmacol., 111, 797, 10.1111/j.1476-5381.1994.tb14808.x

Kennett, 1994, Effect of SB 200646A, a 5-HT2C/5-HT2B receptor antagonist, in two conflict models of anxiety, Psychopharmacology, 118, 178, 10.1007/BF02245837

Kennett, 1996, In vitro and in vivo profile of SB 206553, a potent 5-HT2C/5-HT2B receptor antagonist with anxiolytic-like properties, British Journal of Pharmacology, 117, 427, 10.1111/j.1476-5381.1996.tb15208.x

Kennett, 1988, Evidence that mCPP may have behavioural effects mediated by central 5-HT1C receptors, British Journal of Pharmacology, 94, 137, 10.1111/j.1476-5381.1988.tb11508.x

Kennett, 1991, Potencies of antagonists indicate that 5-HT1C receptors mediate 1-3(chlorophenyl)piperazine-induced hypophagia, British Journal of Pharmacology, 103, 2016, 10.1111/j.1476-5381.1991.tb12369.x

Klodzinska, 1989, Exploratory hypoactivity induced by m-trifluoromethylphenylpiperazine (TFMPP) and m-chlorophenylpiperazine (m-CPP), Journal of Neural Transmission (Parkinsons Disease and Dementia Section), 1, 207, 10.1007/BF02248670

Kursar, 1992, Molecular cloning, functional expression, and pharmacological characterization of a novel serotonin receptor (5-hydroxytryptamine2F) from rat stomach fundus, Molecular Pharmacology, 42, 549

Kursar, 1994, Molecular cloning, functional expression, and mRNA tissue distribution of the human 5-hydroxytryptamine2B receptor, Molecular Pharmacology, 46, 227

Martin, 1994, receptors for 5-hydroxytryptamine: current perspectives on classification and nomenclature, Neuropharmacology, 33, 261, 10.1016/0028-3908(94)90058-2

Mazzola-Pomietto, 1996, Evidence that m-chlorophenylpiperazine-induced hyperthermia in rats is mediated by stimulation of 5-HT2C receptors, Psychopharmacology, 123, 333, 10.1007/BF02246643

McConnell, 1992, The cytosensor microphysiometer: biological applications of silicon technology, Science, 257, 1906, 10.1126/science.1329199

Molineaux, 1989, 5-HT1C receptor is a prominent serotonin receptor subtype in the central nervous system, Proceedings of the National Academy of Science U.S.A., 86, 6793, 10.1073/pnas.86.17.6793

Nozulak, 1995, (+)-cis-4,5,7a,8,9,10,11,11a-octahydro-7H-10-methylindolo[1,7-bc][2,6]-naphthyridine: a 5-HT2C/2B receptor antagonist with low 5-HT2A receptor affinity, Journal of Medical Chemistry, 38, 28, 10.1021/jm00001a007

Saltzman, 1991, Cloning of the human serotonin 5-HT2 and 5-HT1C receptor subtypes, Biochemistry and Biophysics Research Communications, 181, 1469, 10.1016/0006-291X(91)92105-S

Shih, 1991, Molecular biology of serotonin (5-HT) receptors, Pharmacology and Biochemistry of Behaviour, 40, 1053, 10.1016/0091-3057(91)90125-L

Sodhi, 1995, Association between clozapine response and allelic variation in the 5-HT2c receptor gene, Neuroreport, 7, 169, 10.1097/00001756-199512000-00041

Tecott, 1995, Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors, Nature, 374, 542, 10.1038/374542a0

Trail, 1995, Are mCPP-induced behaviours 5-HT2C or 5-HT2B receptors-mediated?, British Journal of Pharmacology, 116, 449P

Ullmer, 1995, Expression of serotonin receptor mRNAs in blood vessels, FEBS Letters, 370, 215, 10.1016/0014-5793(95)00828-W

Weinhardt, 1996, Some benzenesulfonamido-substituted Valerophenones that are selective antagonists for the 5-HT2C receptor, Bioorganics and Medical Chemistry Letters, 6, 2687, 10.1016/S0960-894X(96)00503-3